Pemetrexed-induced edema of the eyelid

Lung Cancer

Volumn 69, Issue 2, 2010, Pages 249-250

  Guhl, Guillermo ^a   Diaz Ley, Blanca ^a   Sanchez Perez, Javier ^a   Jimenez, Ulpino ^a   Garcia Diez, Amaro ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; PACLITAXEL; PEMETREXED;

AGED; BONE MARROW SUPPRESSION; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; ERYTHEMA; EYELID EDEMA; HUMAN; LETTER; LIVER METASTASIS; LUNG ADENOCARCINOMA; MALE; MULTIPLE CYCLE TREATMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT RESPONSE;

AGED; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DEXAMETHASONE; DRUG ERUPTIONS; EDEMA; EYELIDS; GLUTAMATES; GUANINE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING;

EID: 77954141954     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.04.024     Document Type: Letter

References (9)

1. Hanna N., Shepherd F.A., Fossella F.V., Pereira J.R., De Marinis F., von Pawel J., et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004, 22(9):1589-1597.
2. Cohen M.H., Johnson J.R., Wang Y.C., Sridhara R., Pazdur R. FDA drug approval summary: pemetrexed for injection (Alimta) for the treatment of non-small cell lung cancer. Oncologist 2005, 10(6):363-368.
3. Clarke S.J., Abratt R., Goedhals L., Boyer M.J., Millward M.J., Ackland S.P. Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naive patients with advanced non-small-cell lung cancer. Ann Oncol 2002, 13(5):737-741.
4. Lopes G., Vincek V., Raez L.E. Pemetrexed-associated urticarial vasculitis. Lung Cancer 2006, 51(2):247-249.
5. Tummino C., Barlesi F., Tchouhadjian C., Tasei A.M., Gaudy-Marqueste C., Richard M.A., et al. Severe cutaneous toxicity after pemetrexed as second line treatment for a refractory non small cell lung cancer. Rev Mal Respir 2007, 24(5):635-638.
6. Kurata T., Tamura K., Okamoto I., Satoh T., Nakagawa K., Fukuoka M. Pemetrexed-induced edema of the eyelid. Lung Cancer 2006, 54(2):241-242.
7. Esmaeli B., Prieto V.G., Butler C.E., Kim S.K., Ahmadi M.A., Kantarjian H.M., et al. Severe periorbital edema secondary to STI571 (Gleevec). Cancer 2002, 95(4):881-887.
8. Maalouf T., Angioi K., Champigneulle J., Guerci A., George J.L. Palpebral edema secondary to treatment by a specific inhibitor of tyrosine kinase: Glivec. A case report. J Fr Ophtalmol 2004, 27(1):107-109.
9. Pietras K., Ostman A., Sjoquist M., Buchdunger E., Reed R.K., Heldin C.H., et al. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 2001, 61(7):2929-2934.